Anthurium blight caused by the bacterium Xanthomonas axonopodis (formerly campestris) pv. dieffenbachiae McCull & Pirone (Xad) has become a serious threat to the global anthurium industry, resulting in the devastation of many Caribbean and Pacifi c farms during the 1990s. Anthurium blight is also present in the Netherlands, a major exporter of anthurium cut fl owers and leaves (Sathyanarayana et al., 1998) . In Hawaii, which produces about one-fi fth of the world's supply of cut fl ower anthurium, stringent sanitation and control practices have reduced the disease incidence, but infection persists in the fi eld Nishijima, 1988) . transgenic plants; only later were such reports published (Arce et al., 1999; Ko et al., 2000 Ko et al., , 2002 Norelli et al., 1994; Reynoird et al., 1999) . However, we chose to re-direct our efforts to testing of the cecropin analogue Shiva-1 due to its higher antibacterial activity in vitro against Xad (LD 100 of 0.45 µM attacin vs 0.3 µM Shiva-1 at 3 × 10 3 cfu/mL Xad·150) and a fi rst report of Shiva-1 effectiveness in transgenic plants .
Disease resistance, delayed symptom expression or decreased plant mortality were observed in several model and crop plants bioengineered for the Shiva-1 or SB-37 lytic peptides when challenged with the major bacterial pathogens Ralstonia (formerly Pseudomonas) solanacearum Smith or Erwinia carotovora subsp. (Arce et al., 1999; Hassan et al., 1993; Jaynes et al., 1993) . Our early work with anthurium produced 36 plants of selection 'UH1060' positive for SB-37 or Shiva-1 expression by reverse transcription polymerase chain reaction (RT-PCR) analysis, with thirteen (13%) producing detectable levels of peptide. Four of the thirteen (31%) peptide-positive plants showed disease attenuation not seen among 34 nontransgenic controls when sprayinoculated with 10 4 cfu/mL Xad·in unreplicated trials .
Here we report on bacterial blight tolerance tests for two commercial anthurium cultivars, 'Paradise Pink' and 'Tropic Flame', transgenic for Shiva-1 and tested in replicated disease trials. Results show that Shiva-1 signifi cantly enhanced disease tolerance in one cultivar, but unexpectedly enhanced disease susceptibility in another.
Materials and Methods
Shiva-1 transgenics. 'Paradise Pink' (PP) is a heart-shaped blight susceptible cultivar and 'Tropic Flame' (TF) is a tulip-shaped blight susceptible cultivar (Kamemoto and Kuehnle, 1996) . Plants transgenic for Shiva-1 were obtained using the pBPRS1 plasmid containing the PR1b secretion signal (Denecke et al., 1990) for Shiva-1 driven by a 35-35S CaMV promoter following the transformation protocol of Kuehnle et al. (2001) . The process of Agrobacterium treatment, plant regeneration on selective medium, and molecular analysis by PCR and enzyme linked immunosorbant assay (ELISA) involved three genotypes and took 21 months due to the natural slow growth rate of anthurium. Plantlets expressing the lytic peptide were then selected for clonal micropropagation to establish lines of transformants for a 2-year period. Plants were hardened off in the greenhouse and transplanted to 15-cm pots over the next 2 years. These plants were then rescreened by RT-PCR and northern analyses for Shiva-1 near the completion of the disease challenge.
Shiva-1 peptide quantifi cation. Indirect competitive ELISA (Janssen, 1995) was used to estimate the levels of Shiva-1 peptide in transgenic plant tissue. Leaf samples were frozen in liquid nitrogen and ground in 10× volume of phosphate buffered saline with tween (PBST) + 20% PVP-40 using chilled mortars and pestles. Shiva-1 antigen, 25 ng, was bound Eradication of Xad in the environment has proven diffi cult due to Hawaii's mild climate, the presence of alternative hosts, and use of symptomless infected propagative stock (Norman and Alvarez, 1996) .
Genes encoding peptide biocides have held promise for engineering disease resistance into crops (Jaynes, 1993; Kuehnle et al., 1995) . Of interest to us were two of the three classes of bactericidal proteins identifi ed in the immunized pupae of the giant silkmoth, Hyalophora cecropia: attacins and cecropins . Attacins, at about 20 kDa, show activity against gram-negative bacteria by increasing the permeability of the bacterial outer membrane (Carlsson et al., 1991 (Carlsson et al., , 1998 Hultmark, 1993) . Cecropins, small lytic peptides around 4 kDa, show high and broad potency against both gram-negative and gram-positive bacteria (Huang et al., 1997; Jaynes et al., 1987) by interfering with the inner and outer bacterial membranes (Boman, 1991) . SB-37 and Shiva-1 are synthetic analogs of the natural cecropin B, comprised of 38 amino acids and with similar or increased antibacterial activity .
We obtained transgenic anthurium plants of cultivar 'Rudolph' expressing attacin E while in the process of developing molecular breeding methods for anthurium using Agrobacterium tumefaciens Smith & Townsend (Chen 1993; Chen and Kuehnle, 1996; Kuehnle et al., 2001) . Plantlets showed signifi cant absence or delay in disease symptom development and lower bacterial counts when analyzed by petiole challenge. At that time (pre-1993) no other group had yet reported antibacterial effectiveness of attacin in HORTSCIENCE 39(6): 1327-1331. 2004. to each well of a microtiter plate, incubated 5 to 6 h at 30 °C, then washed 3× with PBST. Each 75-µL plant sample was mixed with 75 µL of a antibody (diluted 1:10,000) and incubated for 1 h at room temperature. The sample-antibody mix was added to coated wells for overnight incubation at 4ºC. Plates were washed 3× with PBST. The antibody conjugate, goat anti-rabbit alkaline phosphatase (1:1000), 50 µL, was added to each well and incubated for 3-6 h at 30 ºC. Plates were washed 3× with PBST. Seventy-fi ve microliters p-nitrophenyl phosphate, (1 mg·mL -1 ) substrate was added to each well, covered, and then incubated in the dark at room temperature. Plates were read on a BioRad ELISA plate reader at OD 405 at 1, 2, 18, and 24 h. Standard curve samples, using peptide added to extracted wild-type plant sap of each genotype, were processed simultaneously with the transgenic tissues.
PCR, RT-PCR, and northern analysis for Shiva-1. DNA was extracted according to Dellaporta et al. (1983) . PCR was performed using Shiva-1 primers 5'-TGCCATCCTTCTTTCTC-GTG-3' and 5'-ATTCTCAACCAACTGC-GCGG-3' that span essentially the entire coding region of Shiva-1, starting within the PR-1 signal peptide sequence, from position 26 to 214 on the gene (Kuehnle et al., 2001 ). The PCR reaction mix contained 2 mM magnesium chloride, 1× PCR buffer, 0.4 µM of each primer, and 2.5 U Taq polymerase in addition to the DNA. A BioRad iCycler was used employing an annealing temperature of 55 ºC for a total of 35 cycles. PCR bands were visualized on 1% w/v agarose gels using standard methods to confi rm positives of the expected 188 bp size. Transgenic samples were verifi ed for transcript expression using RT-PCR. RNA was isolated from greenhouse-grown plants using either the CTAB method (Doyle and Doyle, 1990) or the method outlined in Aragon and Kuehnle (2003) . RT-PCR was initiated using 2 µg total RNA according to a standard RT-PCR protocol from Sambrook and Russell (2001) . PCR amplifi cation using Shiva-1 PCR primers was performed and visualized as above.
Northern blots were used to further analyze anthurium plants that were positive for Shiva-1 by ELISA, PCR, and RT-PCR. RNA samples were prepared (Aragon and Kuehnle, 2003) and total RNA was examined by electrophoresis in a 1.5% w/v denaturing agarose gel using the method outlined in Champagne and Kuehnle (2000) . Total RNA, 15 µg, was loaded per lane for northern analysis. Blots were prepared following Sambrook and Russell (2001) and subsequently probed with a 32 P-labeled Shiva-1 PCR-generated probe of 188 bp that encompasses the coding sequence of Shiva-1 with an expected RNA of about 340 bp, including the 3'-UTR and the poly(A) tail .
Bacterial challenge of Shiva-1 plants by spray-inoculation. Xanthomonas axonopodis pv. dieffenbachiae V108LRUH1 (Xad·lux), a bioluminescent strain, was used to monitor bacterial infection in leaves . Bacterial inoculum was prepared and used at 10 8 cfu/mL Xad·lux or 10 5 cfu/mL Xad·lux for spray-inoculation to run-off on every leaf; control plants were sprayed with sterile water. Plants were sealed in bags overnight at 23 ºC, then grown under 70% shade in a greenhouse with hand-watering every other day. Average minimal and maximum temperatures were 23.9 and 31.6 ºC, conducive for blight development. The luminescence of Xad·lux was used to monitor the internal progression of leaf infection to determine disease severity. Light produced by Xad·lux was detected in a darkroom using X-ray fi lm, attached for 7 to 8 h to the two youngest fully open leaves (leaf 0 and leaf 1) of each plant, and the infection quantifi ed by the area of exposed fi lm (Fukui et al., , 1998 . Assessments of disease severity were performed at least three times up to 12 weeks postinoculation. Disease incidence was also recorded at each monitoring date as the number of replicated plants per line showing visual symptoms (water-soaking, necrosis) on the two leaves examined for bioluminescence. At 12 weeks postinoculation the percentage of all leaves showing visual symptoms and the total number of infection sites (based on three to four mature leaves per plant) were also recorded for plants treated with 10 5 cfu/mL Xad·lux.
Five transgenic lines of 'Paradise Pink' (PP) and eight transgenic lines of 'Tropic Flame' (TF), six replicates each, were challenge-inoculated with 10 8 cfu/mL Xad·lux in a fi rst trial. Lines PP 1-2, PP 1-4, TF 1-1, TF 1-9, and TF 1-16 were selected for a second bacterial challenge with 10 5 cfu/mL Xad·lux. Each transgenic line as well as the nontransgenic TF control consisted of eight to ten plant replications in the second challenge. Nontransgenic 'Rudolph', with six to seven replicates, was substituted for PP susceptible controls since PP plants of comparable size were unavailable at the time of inoculation; 'Rudolph' later was shown to be equivalent to PP in disease progression (see Results). Cultivar 'Kalapana', with fi ve to six replicates, was included as a blight tolerant (Fukui et al., 1998) reference line. 'Kalapana' can develop foliar blight but rarely goes systemic in the grower's fi eld. 'Paradise Pink' and 'Rudolph' typically develop foliar symptoms of water-soaked and necrotic spots, starting at the leaf margin due to entry at the hydathodes, followed by systemic infection leading to a yellowing of entire leaf blades, stem rot, and plant wilting. TF symptoms include a more pronounced localized necrosis of leaves before systemic infection. Statistical analysis. Statistical analysis for disease severity based on bioluminescence of PP and TF plants was performed using percent infection data from leaf 0 and leaf 1. Mean values of the fi ve to ten replications for each anthurium line were subjected to analysis of variance using the nonparametric general linear model (RANK) of SAS (SAS Institute, Cary, N.C.). The RANK procedure assigned rankings to the percentage data and the rankings were subjected to analysis of variance. Mean rankings were separated by the Student-Newman-Keuls (SNK) test.
Results

Challenge-inoculation of Shiva-1 transformants.
Results from PCR, ELISA, and RT-PCR performed on clones over a period of several years indicated that all anthurium lines propagated for disease challenge stably maintained the Shiva-1 inserted DNA and expressed the Shiva-1 transcript, with an expected RT-PCR amplifi ed band size of about 200 bp (Fig. 1) . Towards the end of the fi nal challenge experiment, blighted plants from all fi ve transgenic lines of interest were again analyzed for Shiva-1 expression. Northern blots showed a single band at about 340 bp for all transgenic plants examined, regardless of their disease susceptibility (Fig. 2) . There was no band detected for nontransgenic TF and PP plants.
Peptide levels were measured in the original mother stock plants at the onset of micropropagation. Shiva-1 concentrations were 0.19, 0.38, and 0.16 µM for TF 1-1, TF 1-9 and TF 1-16, respectively. Peptide concentrations were 0.13 and 0.06 µM for PP 1-2 and PP 1-4, respectively. Our estimates of Shiva-1 peptide may be considerably lower than what is actually in the transgenic plants, due to the use of leaf extracts in the assay system and the lack of any protease inhibitor to reduce degradation of Shiva-1 by the plant sap (Florack et al., 1995) . Li et al. (2001) showed that mixing leaf extracts with Shiva-1 peptide standards reduced the quantity of peptide by as much as 50-fold, presumably due to protease activity in the leaf extracts. An adjustment of 50-fold increases the values for transgenic anthurium (8 to 19 µM for 'Tropic Flame'; 3 to 6.5 µM for 'Paradise Pink') to well within the range detected by Li et al. (2001) in transgenic grapevine leaves (5.7 to 15 µM).
'Paradise Pink' inoculated with 10 8 cfu/mL Xad·lux. Leaf infection was monitored at 4, 6, 7, 9, and 12 weeks postinoculation for transgenic lines and controls 'Kalapana' and 'Rudolph'. At four weeks postinoculation all lines displayed foliar symptoms and by week 12 all lines including the resistant check 'Kalapana' were systemically infected. However, 'Kalapana' consistently had the lowest disease severity in leaf 0 and leaf 1 at all monitoring dates (Table 1) . According to the analysis of variance, the effects of plant line on disease severity (assessment of leaf 0 and leaf 1) at all dates were not signifi cantly different at P ≤ 0.05. However, when symptoms in leaf 1 were evaluated over time, disease seemed to progress slower among transgenic lines in PP 1-2 and PP 1-4 from 4 to 9 weeks postinoculation under such high inoculum. These two lines were selected for a second bacterial challenge using lower inoculum levels.
'Paradise Pink' inoculated with 10 5 cfu/mL Xad·lux. At 6 weeks postinoculation, rankings of disease severity were not signifi cantly different at P ≤ 0.05 among all lines (Table  2) . At 8 weeks, infection advanced markedly in 'Rudolph' and was signifi cantly higher in 'Rudolph' leaf 0 (21%) than in the other lines (P > F = 0.0006). At 12 weeks, the last monitoring date, transgenic 'Paradise Pink' plants displayed equal or higher tolerance to Xad·lux than the blight tolerant 'Kalapana' and much higher tolerance than the blight susceptible 'Rudolph' (Table 2) . Blight symptoms on the evaluated leaves matched the bioluminescent data, with symptoms on only 1 of 10 plants to 3 of 10 plants of PP 1-2 and PP 1-4 compared to 4 of 5 plants to 7 of 7 plants of 'Rudolph' and 'Kalapana' replicate plants. No signifi cant difference in disease tolerance was determined between PP 1-2 and PP 1-4. Once 'Paradise Pink' plants of adequate size were available, 'Rudolph' was subsequently confi rmed as an equivalent susceptible control. Results at 12 weeks postinoculation with Xad·lux showed infection in 4 of 5 PP plants with 35% to 75% disease severity and in 5 of 5 'Rudolph' plants with 3% to 100% disease severity.
'Tropic Flame' inoculated with 10 8 cfu/mL Xad·lux. Leaf infection was monitored at 6, 8 and 12 weeks postinoculation. At 6 weeks postinoculation no disease was detected by bioluminescence in any of the anthurium lines. At 8 and 12 weeks symptoms were detectable although disease severity was not signifi cantly different (P ≤ 0.05) among the lines (Table 3) . When disease progression in leaf 0 and leaf 1 was examined, three transgenic lines, TF 1-1, TF 1-8, and TF 1-9, seemed to show delayed symptom development compared to the other transgenic lines. TF 1-1 and TF 1-9 were selected for a second challenge under lower inoculum levels along with TF 1-16, a line showing the greatest symptoms at week 12 (Table 3) . Clonal plants of TF 1-8 were unavailable for a second challenge.
'Tropic Flame' inoculated with 10 5 cfu/mL Xad·lux. At 6 weeks postinoculation, disease severity in TF 1-16 leaf 0 (4%) was already signifi cantly higher (P > F = 0.0028) than the other transgenic lines and the control (0% to 1.7%; Table 4 ). A high percentage of TF 1-16 plants displayed blight symptoms (leaf 0, 67% and leaf 1, 56%) compared to TF 1-1 (both leaves 0%), TF 1-9 (leaf 0, 20% and leaf 1, 40%), and TF control (both leaves 10%). Trends toward increased disease severity and disease incidence in TF 1-16 continued through At 12 weeks postinoculation, the disease severity index increased to 45% for TF 1-16, signifi cantly higher (P > F = 0.0005, leaf 0 and P > F = 0.0038, leaf 1) than the other TF lines at 0% to 13% (Table 4) . Disease incidence in TF 1-16 reached a high of 78% of the plants for leaf 0 and 67% of the plants for leaf 1, up from 67% and 56%, respectively at week 8. Disease incidence remained modest in the TF control for leaf 0 at 20% and leaf 1 at 40%, up from 10% or unchanged from week 8; it remained low and unchanged over time for both transgenic lines (TF 1-1 leaf 0, 0% and leaf 1, 10%; TF 1-9, leaf 0, 20% and leaf 1, 10%). Bioluminescence data from all sampled leaves shows that TF 1-16 had enhanced susceptibility to blight over the control and the two other Shiva-1 transgenic lines. There was no difference in blight response among TF 1-1, TF 1-9, and the control. In a lane-by-lane comparison of northern results, TF 1-16 had much lower Shiva-1 expression than TF 1-9 (Fig. 2, lanes 3 and  4) . A comparison of the 18S RNA bands on the RNA gel reveals that the lane for TF 1-16 actually contains more total RNA loaded than TF 1-9 (Fig. 3, lanes 3 and  4) . The lower amount of RNA loaded for TF 1-1 (Fig. 3, lane 2) compared to TF 1-9 (Fig.  3, lane 3) explains the slightly weaker band for that transgenic line. These results were repeated in subsequent northern analysis (data not shown).
Representative X-ray fi lms of inoculated leaves are shown in Fig. 4 . Xad·lux was already heavily systemic by week 6 in the susceptible check 'Rudolph' (Fig. 4B ) and in transgenic TF 1-16 (Fig. 4C) as seen by the black regions on bioluminescence-exposed fi lm. Infection was only marginal in transgenic PP1-4 (Fig. 4A) or at the beginning stage of vascular entry in TF wild-type (Fig. 4D) .
Discussion
In this study we adopted a nondestructive means (bacterial bioluminescence) to assess and quantify disease progression in transgenic plants. This assured that infected plants which harbored high bacterial counts yet remained symptomless (i.e., those with latent infection) did not escape detection. Using this means of assessment, transgenic 'Paradise Pink' displayed signifi cantly enhanced tolerance to bacterial blight at an inoculum level that may be found in aerosols in the fi eld. Although complete resistance was not obtained, a blight tolerance level that exceeds that of a "resistant" industry standard such as 'Kalapana' is nevertheless meaningful under fi eld conditions. We intend to combine engineered tolerance with use of benefi cial bacteria (Fujii et al., 2002; Fukui et al., 1999) to further reduce the plant inoculum levels in the fi eld in an effort to maximize protection against bacterial blight for this perennial crop. Moreover, peptide quantifi cation showed that the transgenic 'Paradise Pink' lines produced less Shiva-1 relative to 'Tropic Flame' lines, which did not display enhanced tolerance to blight. Secretion of the peptide into intercellular spaces was not determined. Nevertheless, these results may indicate that different genotypes of the same crop require different amounts of Shiva-1 to have a measurable effect on enhancing blight tolerance. Different crops have already been shown to vary in their degradation of lytic peptides by intercellular fl uids (Owens and Heutte, 1997; Sharma et al., 2000) . This variation is thought to account for the failed resistance in transgenic tobacco (Florack et al., 1995; Hightower et al., 1994) .
Bioluminescence data from 'Tropic Flame' showed that at least one transgenic line, TF 1-16, had enhanced susceptibility to blight over the wild-type control. Disease onset was swift and bacteria proliferated much more rapidly in the leaf tissues compared with controls. Jaynes et al. (1993) also observed elevated disease symptoms in some tobacco plants transgenic for Shiva-1 when inoculated with Ralstonia solanacearum. They attributed this to a cell proliferation effect of peptides at low concentrations. In vitro, Peptidyl MIM 2L2, another synthetic cecropin analog, increased cell titers of Acholeplasma laidlawii 20% to 30% (Borth et al., 2001 ) at certain concentrations. These results taken together with the low level of Shiva-1 expression in 'Tropic Flame' 1-16 suggest that a sub-optimal level of Shiva-1 may actually increase disease susceptibility to anthurium blight in at least one genotype. An in vitro toxicity assay using Shiva-1 in buffer showed a dosage response of Xad·lux growth, rather than a threshold response seen with other bacterial species endogenous to anthurium, with no increase in proliferation of Xad·lux at the lowest Shiva-1 concentration tested (0.125 µM; Fujii et al., 2002) . Nevertheless, if it is correct that a lower level of expression of Shiva-1 is the cause of the increased susceptibility to Xad·lux in the transgenic 'Tropic Flame' line, then one should test if down-regulation of a transgene, (i.e., under an environmental stress such as nematode infestation) could render an otherwise resistant transgenic cultivar to become more prone to systemic anthurium blight.
